Core Laboratories N.V. (CLB) Reaches $128.68 52-Week High; Shorts at Cadiz (CDZI) Raised By 10.59%

May 18, 2018 - By Mary Manson

Cadiz Inc. (NASDAQ:CDZI) Logo

The stock of Core Laboratories N.V. (NYSE:CLB) hit a new 52-week high and has $132.54 target or 3.00% above today’s $128.68 share price. The 7 months bullish chart indicates low risk for the $5.69B company. The 1-year high was reported on May, 18 by Barchart.com. If the $132.54 price target is reached, the company will be worth $170.64 million more. The stock decreased 0.12% or $0.155 during the last trading session, reaching $128.675. About 11,814 shares traded. Core Laboratories N.V. (NYSE:CLB) has declined 4.05% since May 18, 2017 and is downtrending. It has underperformed by 15.60% the S&P500.

Cadiz Inc (NASDAQ:CDZI) had an increase of 10.59% in short interest. CDZI’s SI was 2.56M shares in May as released by FINRA. Its up 10.59% from 2.32M shares previously. With 209,300 avg volume, 12 days are for Cadiz Inc (NASDAQ:CDZI)’s short sellers to cover CDZI’s short positions. The SI to Cadiz Inc’s float is 14.46%. The stock increased 0.20% or $0.025 during the last trading session, reaching $12.725. About 18,426 shares traded. Cadiz Inc. (NASDAQ:CDZI) has declined 5.84% since May 18, 2017 and is downtrending. It has underperformed by 17.39% the S&P500.

Investors sentiment increased to 1.09 in Q4 2017. Its up 0.01, from 1.08 in 2017Q3. It improved, as 5 investors sold Cadiz Inc. shares while 17 reduced holdings. 7 funds opened positions while 17 raised stakes. 11.34 million shares or 2.29% more from 11.09 million shares in 2017Q3 were reported. Citigroup accumulated 0% or 3,169 shares. Teton Advisors reported 0.06% in Cadiz Inc. (NASDAQ:CDZI). Legal & General Gru Public Limited Liability Company invested in 0% or 3,489 shares. Morgan Stanley holds 0% or 43,109 shares in its portfolio. 203,546 are held by Geode Capital Mgmt Limited Company. Kbc Gru Nv owns 209,838 shares. Elkhorn Prtn Limited Partnership reported 451,821 shares. Raymond James And Assoc has 0% invested in Cadiz Inc. (NASDAQ:CDZI) for 12,000 shares. Kings Point Cap Mngmt invested 0.22% in Cadiz Inc. (NASDAQ:CDZI). Northern Trust Corporation stated it has 0% in Cadiz Inc. (NASDAQ:CDZI). Janney Montgomery Scott Lc holds 38,300 shares. Aqr Cap Mgmt Ltd Llc accumulated 15,580 shares. Moreover, Parallax Volatility Advisers Lp has 0% invested in Cadiz Inc. (NASDAQ:CDZI). Royal Bank Of Canada has 2,940 shares. Metropolitan Life Insurance Com New York invested in 6,449 shares or 0% of the stock.

More news for Cadiz Inc. (NASDAQ:CDZI) were recently published by: Seekingalpha.com, which released: “Cadiz: A Risky Potential Short” on April 23, 2018. Streetinsider.com‘s article titled: “Cadiz (CDZI) Board to Add Representatives From Water Asset Management” and published on May 02, 2018 is yet another important article.

Cadiz Inc. operates as a land and water resource development firm in the United States. The company has market cap of $298.02 million. It engages in the water resource, and land and agricultural development activities in San Bernardino County properties. It currently has negative earnings. The firm owns approximately 34,000 acres of land and the subsurface strata, including unsaturated soils and appurtenant water rights in the Cadiz and Fenner valleys of eastern San Bernardino County; and approximately 11,000 acres in the Mojave Desert in eastern San Bernardino County.

Investors sentiment decreased to 0.86 in 2017 Q4. Its down 0.21, from 1.07 in 2017Q3. It is negative, as 52 investors sold Core Laboratories N.V. shares while 109 reduced holdings. 54 funds opened positions while 85 raised stakes. 49.56 million shares or 0.63% more from 49.25 million shares in 2017Q3 were reported. Royal Bancorporation Of Canada invested 0% of its portfolio in Core Laboratories N.V. (NYSE:CLB). Tiaa Cref Invest Mgmt Limited Liability Corporation has invested 0% in Core Laboratories N.V. (NYSE:CLB). Opportunities Capital Management Limited has 42,101 shares. Suntrust Banks holds 2,942 shares or 0% of its portfolio. First Manhattan stated it has 0% of its portfolio in Core Laboratories N.V. (NYSE:CLB). Atlantic Group Lc, Georgia-based fund reported 3,565 shares. Bb&T Ltd Llc holds 0.03% of its portfolio in Core Laboratories N.V. (NYSE:CLB) for 17,694 shares. Btim owns 0.11% invested in Core Laboratories N.V. (NYSE:CLB) for 70,661 shares. Snyder Cap Management L P invested 0.19% in Core Laboratories N.V. (NYSE:CLB). Da Davidson And Comm owns 6,320 shares or 0.01% of their US portfolio. Wells Fargo Mn stated it has 0.02% of its portfolio in Core Laboratories N.V. (NYSE:CLB). Retirement Of Alabama holds 0.03% in Core Laboratories N.V. (NYSE:CLB) or 57,037 shares. Bokf Na has 0.02% invested in Core Laboratories N.V. (NYSE:CLB). Renaissance Technologies Lc holds 0.01% of its portfolio in Core Laboratories N.V. (NYSE:CLB) for 70,200 shares. Winfield Assoc owns 5 shares.

Analysts await Core Laboratories N.V. (NYSE:CLB) to report earnings on July, 23. They expect $0.65 earnings per share, up 25.00% or $0.13 from last year’s $0.52 per share. CLB’s profit will be $28.73M for 49.49 P/E if the $0.65 EPS becomes a reality. After $0.57 actual earnings per share reported by Core Laboratories N.V. for the previous quarter, Wall Street now forecasts 14.04% EPS growth.

More important recent Core Laboratories N.V. (NYSE:CLB) news were published by: Seekingalpha.com which released: “Core Labs Earnings Preview” on April 25, 2018, also Seekingalpha.com published article titled: “Core Laboratories Remains Highly Overvalued”, Seekingalpha.com published: “Core Labs: Stock Price Continues To Confound Its Intrinsic Value” on May 09, 2018. More interesting news about Core Laboratories N.V. (NYSE:CLB) was released by: Fool.com and their article: “3 Energy Stocks to Buy in May” with publication date: May 15, 2018.

Among 23 analysts covering Core Laboratories (NYSE:CLB), 12 have Buy rating, 0 Sell and 11 Hold. Therefore 52% are positive. Core Laboratories has $155 highest and $80 lowest target. $115.35’s average target is -10.36% below currents $128.675 stock price. Core Laboratories had 55 analyst reports since August 24, 2015 according to SRatingsIntel. The rating was maintained by Piper Jaffray with “Hold” on Monday, July 24. The firm has “Hold” rating given on Wednesday, August 30 by Cowen & Co. As per Friday, October 23, the company rating was maintained by RBC Capital Markets. RBC Capital Markets maintained it with “Buy” rating and $14500 target in Friday, June 16 report. The stock has “Buy” rating by Loop Capital on Friday, April 21. Morgan Stanley maintained the shares of CLB in report on Monday, August 7 with “Overweight” rating. JP Morgan initiated it with “Overweight” rating and $120 target in Friday, June 10 report. The firm has “Hold” rating by Cowen & Co given on Friday, April 13. The firm has “Neutral” rating by Credit Suisse given on Thursday, September 1. The firm has “Outperform” rating by Credit Suisse given on Thursday, August 24.

Cadiz Inc. (NASDAQ:CDZI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: